Description
The antibacterial drug segment is the largest and most profitable segment of the global pharmaceuticals market. As antibacterial drugs that develop rapidly in recent years, quinolones are receiving more and more attention from all over the world. As a laevo isomer of Ofloxacin, Levofloxacin has the same antibacterial spectrum, double antibacterial effect, and lower toxicity. Currently, fluoroquinolones are second only to cephalosporins and penicillins on the antibacterial market. Levofloxacin, a third-generation fluoroquinolone, was developed by Daiichi Pharmaceutical Co., Ltd. (merged with Sankyo Co., Ltd. into "Daiichi Sankyo" in 2005) and first marketed in Japan in 1994. In 1995, Levofloxacin APIs and tablets manufactured by Daiichi Pharmaceutical Co., Ltd. were admitted to the Chinese market. After that, Daiichi Pharmaceutical Co., Ltd. established its Chinese subsidiary Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd. with an investment of USD 50 million. The subsidiary produces Levofloxacin preparations in China with the APIs from its parent company. The Levofloxacin tablets produced in China were launched in 1996 under the trade name Cravit. At that time, the retail price was about 7 CNY/tablet. Effective and inexpensive, Cravit saw its sales value rising on the Chinese market. Later, some Chinese companies developed generic Levofloxacin, and extended the dosage forms from tablets to injections, capsules, gels, etc.
According to CRI's market research, in 1998 when it had been launched in China for over one year, Levofloxacin became one of the top 100 drugs by sales value, and then showed an upward trend. The sales value of Levofloxacin declined from 2016 to 2017 after it reached CNY 1.23 billion in 2015. In 2017, China's Levofloxacin market was dominated by Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., China Resources Double-Crane Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory. By sales Value, Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd. captured a market share of 29.1%. The injections, tablets, and eye drops accounted for about 63%, 20% and 13.7% respectively of China's Levofloxacin market. The other dosage forms had a small market share.
As environmental pollution and population aging intensify in China, there will be higher incidences of the main indications for Levofloxacin, for example, respiratory infection, urinary infection and intestinal infection. It is expected that China's Levofloxacin market will still have some growth potential from 2018 to 2022.
Topics Covered:
- Development environment of Levofloxacin in China
- Market size of Levofloxacin in China
- Competitive landscape of China's Levofloxacin market
- Prices of Levofloxacin in China
- Prospect of China's Levofloxacin market from 2018 to 2022
Investigation Report on China's Levofloxacin Market, 2018-2022
Table of Contents
1 Relevant Concepts of Levofloxacin
1.1 Indications for Levofloxacin
1.2 Development of Levofloxacin in China
1.3 Governmental Approval of Levofloxacin in China
2 Sales of Levofloxacin in China, 2013-2017
2.1 Sales Value of Levofloxacin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Levofloxacin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Levofloxacin by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Injections
2.3.4 Eye Drops
2.3.5 Ear Drops
2.3.6 Gels
3 Analysis on Major Levofloxacin Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Levofloxacin Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.'s Levofloxacin in China
3.3 Yangtze River Pharmaceutical (Group) Co., Ltd.
3.3.1 Enterprise Profile
3.3.2 Sales of Yangtze River Pharmaceutical (Group) Co., Ltd.'s Levofloxacin in China
3.4 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory
3.5 Santen Pharmaceutical Co., Ltd.
3.6 China Resources Double-Crane Pharmaceutical Co., Ltd.
4 Prices of Levofloxacin in China, 2017-2018
4.1 Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd. (Cravit)
4.2 Yangtze River Pharmaceutical (Group) Co., Ltd. (Zuoke)
4.3 Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory (Lailixin)
4.4 Santen (Cravit)
4.5 China Resources Double-Crane Pharmaceutical Co., Ltd. (Lifuxing)
5 Prospect of China's Levofloxacin Market, 2018-2022
5.1 Analysis on Factors Influencing China's Levofloxacin Market
5.1.1 Favorable Factors
5.1.2 Unfavorable Factors
5.1 Forecast on Market Size
5.2 Forecast on Market Trend
List of Charts
Chart Sales Value of Levofloxacin in China, 2013-2017
Chart Sales Value of Levofloxacin in Parts of China, 2013-2017
Chart Sales Volume of Levofloxacin in China, 2013-2017
Chart Sales Volume of Levofloxacin in Parts of China, 2013-2017
Chart Sales Value of Levofloxacin Tablets in China, 2013-2017
Chart Sales Volume of Levofloxacin Tablets in China, 2013-2017
Chart Sales Value of Levofloxacin Capsules in China, 2013-2017
Chart Sales Value of Levofloxacin Injections in China, 2013-2017
Chart Sales Value of Levofloxacin Eye Drops in China, 2013-2017
Chart Sales Value of Levofloxacin Ear Drops in China, 2013-2017
Chart Sales Value of Levofloxacin Gels in China, 2013-2017
Chart Market Share of Top 5 Levofloxacin Manufacturers by Sales Value in China, 2013-2017
Chart Market Share of Top 5 Levofloxacin Manufacturers by Sales Volume in China, 2013-2017
Chart Profile of Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.
Chart Sales Value of Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.'s Levofloxacin in China, 2013-2017
Chart Sales Volume of Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.'s Levofloxacin in China, 2013-2017
Chart Profile of Yangtze River Pharmaceutical (Group) Co., Ltd.
Chart Sales Value of Yangtze River Pharmaceutical (Group) Co., Ltd.'s Levofloxacin in China, 2013-2017
Chart Sales Value of Santen's Levofloxacin in China, 2013-2017
Chart Sales Volume of Santen's Levofloxacin in China, 2013-2017
Chart Prices of Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd.'s Levofloxacin (Cravit) in Parts of China, 2017-2018
Chart Prices of Yangtze River Pharmaceutical (Group) Co., Ltd.'s Levofloxacin (Zuoke) in Parts of China, 2017-2018
Chart Prices of Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory's Levofloxacin (Lailixin) in Parts of China, 2017-2018
Chart Prices of Santen's Levofloxacin (Cravit) in Parts of China, 2017-2018
Chart Prices of China Resources Double-Crane Pharmaceutical Co., Ltd.'s Levofloxacin in Parts of China, 2017-2018
Chart Forecast on Sales Value of Levofloxacin in China, 2018-2022
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
